BSE filing, NSE: UNJHAFOR. Summary written from the filing by ALFA Finder's alert engine.
Unjha Formulations Ltd: key numbers
- Share price
- ₹26.99
- Market cap
- ₹12.09 Cr
- Revenue (annual)
- ₹15.59 Cr
- Net profit (annual)
- ₹0.70 Cr
- P/E (TTM)
- 25.6×Sector 46.1×
- Promoter holding
- 36.92%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Unjha Formulations Ltd
All →Unjha Formulations Board Meeting Date
Unjha Formulations intimated BSE of a board meeting on 05/11/2026. It will consider un-audited half-year and quarter results ended 30.09.2026.
Unjha Formulations Other Announcement
Unjha Formulations filed its Regulatory 40(9) compliance certificate for the half-year ended 30.09.2026. The practicing company secretary confirmed timely share-certificate issuance.
Unjha Formulations Other Announcement
Unjha Formulations Ltd has submitted its quarterly shareholding pattern statement for the period ended September 30, 2026, as required by SEBI regulations.
Unjha Formulations Financial Results
Unjha Formulations filed the XBRL/XML financial statements for year ended 31/03/2026 with BSE. The submission includes Balance Sheet, P&L, and Cash Flow under SEBI LODR.
Unjha Formulations Other Announcement
Unjha Formulations Limited filed its shareholding distribution schedule as of March 31, 2026, pursuant to SEBI regulations. This is a routine compliance disclosure regarding shareholder distribution.
Unjha Formulations Annual General Meeting
Unjha Formulations Limited conducted its 32nd Annual General Meeting on August 14, 2026. Members transacted business including the adoption of financial statements and director appointments.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.